Estimates Revisions Spyre Therapeutics, Inc. Deutsche Boerse AG
Stocks
3920
US00773J2024
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:09:06 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 74.00 EUR | 0.00% |
|
-6.33% | +170.07% |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $2,480,529, According to a Recent SEC Filing | MT |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $1,309,410, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- SYRE Stock
- 3920 Stock
- Consensus Spyre Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
